ASCO: New antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer (IMAGE)

University of Texas M. D. Anderson Cancer Center

ASCO: New antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer

Caption

ASCO: New antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer

Credit

The University of Texas MD Anderson Cancer Center

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.